Martini N, Preckel B, Thämer V, Schlack W
Institut für Klinische Anaesthesiologie, Heinrich-Heine-Universität Düsseldorf, Germany.
Br J Anaesth. 2001 Feb;86(2):269-71. doi: 10.1093/bja/86.2.269.
Ischaemic preconditioning can protect the myocardium against ischaemic injury by opening of the adenosine triphosphate (ATP)-sensitive potassium (K(ATP)) channel. Isoflurane is also thought to open this channel. The present investigation tested the hypothesis that pre-ischaemic treatment with isoflurane mimics ischaemic preconditioning (producing chemical preconditioning) and thereby protects the myocardium against ischaemic injury in an isolated rat heart model. Control hearts underwent 30 min of global no-flow ischaemia followed by 60 min of reperfusion. The hearts of the preconditioning group underwent two 5 min periods of no-flow ischaemia interspersed with 5 min of reperfusion before the sustained ischaemia. In three additional groups, hearts were subjected to 15 min of 1.5 minimal alveolar concentration (MAC) of isoflurane (ISO-1), 15 min 3 MAC (ISO-2) or 25 min 1.5 MAC (ISO-3) of isoflurane followed by 5 min washout before the global ischaemia. Left ventricular (LV) developed pressure and creatine kinase release were measured as variables of myocardial performance and cellular injury, respectively. Recovery of LV developed pressure was improved after ischaemic preconditioning [after 60 min reperfusion, mean 63 (SEM 6)% of baseline] compared with the control group [18 (4)% P<0.01] but not by isoflurane, independently of concentration or duration of administration [ISO-1, 17 (2)%, P=0.99 vs control; ISO-2, 12 (3)%, P=0.64; ISO-3, 4 (1)%, P=0.06]. Total creatine kinase release over 1 h of reperfusion was not significantly different between control [251 (36) U g(-1) dry weight] and all isoflurane groups [ISO-1, 346 (24) U g(-1), P=0.30; ISO-2, 313 (33) U g(-1), P=0.73; ISO-3, 407 (40) U g(-1), P=0.03]. These results indicate that pre-ischaemic administration of isoflurane does not cause anaesthetic-induced preconditioning in the isolated rat heart.
缺血预处理可通过开放三磷酸腺苷(ATP)敏感性钾(K(ATP))通道来保护心肌免受缺血性损伤。异氟烷也被认为可开放此通道。本研究检验了如下假设:在离体大鼠心脏模型中,缺血前给予异氟烷可模拟缺血预处理(产生化学预处理),从而保护心肌免受缺血性损伤。对照组心脏经历30分钟全心无血流缺血,随后再灌注60分钟。预处理组心脏在持续性缺血前经历两个5分钟的无血流缺血期,期间穿插5分钟再灌注。在另外三组中,心脏在全心缺血前先接受15分钟1.5最低肺泡浓度(MAC)的异氟烷(ISO-1组)、15分钟3MAC(ISO-2组)或25分钟1.5MAC(ISO-3组)的异氟烷处理,随后冲洗5分钟。分别测量左心室(LV)舒张末压力和肌酸激酶释放量,作为心肌功能和细胞损伤的指标。与对照组相比,缺血预处理后LV舒张末压力的恢复得到改善(再灌注60分钟后,平均为基线的63(标准误6)%),而对照组为18(4)%,P<0.01;但异氟烷处理组未改善,与给药浓度或持续时间无关[ISO-1组,17(2)%,与对照组相比P=0.99;ISO-2组,12(3)%,P=0.64;ISO-3组,4(1)%,P=0.06]。再灌注1小时内总的肌酸激酶释放量在对照组[251(36)U g(-1)干重]和所有异氟烷处理组之间无显著差异[ISO-1组,346(24)U g(-1),P=0.30;ISO-2组,313(33)U g(-1),P=0.73;ISO-3组,407(40)U g(-1),P=0.03]。这些结果表明,缺血前给予异氟烷不会在离体大鼠心脏中引起麻醉诱导的预处理。